192 related articles for article (PubMed ID: 9108888)
1. TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity.
Barrack ER
Prostate; 1997 Apr; 31(1):61-70. PubMed ID: 9108888
[TBL] [Abstract][Full Text] [Related]
2. Modulation of transforming growth factor beta 1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix.
Morton DM; Barrack ER
Cancer Res; 1995 Jun; 55(12):2596-602. PubMed ID: 7780974
[TBL] [Abstract][Full Text] [Related]
3. Expression of transforming growth factor-beta 1 in prostate cancer.
Steiner MS; Zhou ZZ; Tonb DC; Barrack ER
Endocrinology; 1994 Nov; 135(5):2240-7. PubMed ID: 7956947
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro.
Steiner MS; Barrack ER
Mol Endocrinol; 1992 Jan; 6(1):15-25. PubMed ID: 1738367
[TBL] [Abstract][Full Text] [Related]
5. Potential role of HBGF (FGF) and TGF-beta on prostate growth.
Matuo Y; McKeehan WL; Yan GC; Nikolaropoulos S; Adams PS; Fukabori Y; Yamanaka H; Gaudreau J
Adv Exp Med Biol; 1992; 324():107-14. PubMed ID: 1492611
[TBL] [Abstract][Full Text] [Related]
6. Peptide growth factors in the prostate as mediators of stromal epithelial interaction.
Byrne RL; Leung H; Neal DE
Br J Urol; 1996 May; 77(5):627-33. PubMed ID: 8689101
[TBL] [Abstract][Full Text] [Related]
7. TGF-betal/Smad signaling in prostate cancer.
Bello-DeOcampo D; Tindall DJ
Curr Drug Targets; 2003 Apr; 4(3):197-207. PubMed ID: 12643470
[TBL] [Abstract][Full Text] [Related]
8. Effects of transforming growth factor beta 1 on the adenylyl cyclase-cAMP pathway in prostate cancer.
Steiner MS; Wand GS; Barrack ER
Growth Factors; 1994; 11(4):283-90. PubMed ID: 7779408
[TBL] [Abstract][Full Text] [Related]
9. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
Guo Y; Kyprianou N
Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
[TBL] [Abstract][Full Text] [Related]
10. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
[TBL] [Abstract][Full Text] [Related]
11. Mammalian target of rapamycin and 3-phosphatidylinositol 3-kinase pathway inhibition enhances growth inhibition of transforming growth factor-beta1 in prostate cancer cells.
van der Poel HG
J Urol; 2004 Oct; 172(4 Pt 1):1333-7. PubMed ID: 15371835
[TBL] [Abstract][Full Text] [Related]
12. Stromal inhibition of prostatic epithelial cell proliferation not mediated by transforming growth factor beta.
Kooistra A; van den Eijnden-van Raaij AJ; Klaij IA; Romijn JC; Schröder FH
Br J Cancer; 1995 Aug; 72(2):427-34. PubMed ID: 7543773
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
Song K; Cornelius SC; Danielpour D
Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta in benign and malignant prostate.
Lee C; Sintich SM; Mathews EP; Shah AH; Kundu SD; Perry KT; Cho JS; Ilio KY; Cronauer MV; Janulis L; Sensibar JA
Prostate; 1999 Jun; 39(4):285-90. PubMed ID: 10344218
[TBL] [Abstract][Full Text] [Related]
15. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
Cipriano SC; Chen YQ
Oncogene; 1998 Sep; 17(12):1549-56. PubMed ID: 9794232
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta expression in prostate neoplasia.
Cardillo MR; Petrangeli E; Perracchio L; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Feb; 22(1):1-10. PubMed ID: 10696454
[TBL] [Abstract][Full Text] [Related]
17. The role for transforming growth factor-beta (TGF-beta) in human cancer.
Gold LI
Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
[TBL] [Abstract][Full Text] [Related]
18. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
[TBL] [Abstract][Full Text] [Related]
19. Malignant cells, directors of the malignant process: role of transforming growth factor-beta.
Teicher BA
Cancer Metastasis Rev; 2001; 20(1-2):133-43. PubMed ID: 11831642
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
